source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Blacktrace expands its presence in Japan with new office in Kanagawa

Blacktrace logo 3.12.18Blacktrace has increased its presence in Japan by opening a new office in Kanagawa and doubling its sales team in order to help the company meet increasing demand for its product development services from the biology, chemistry and microfluidics sectors. The expansion increases the Japanese sales team’s ability to support customers working in the rapidly growing area of single-cell genomics: Blacktrace’s newest brand, Dolomite Bio, is a key technology provider in this field, where its Nadia Instrument is helping to accelerate disease research and drug discovery in areas such as oncology and neurology.

The microfluidics and flow chemistry markets are also experiencing year-on-year growth in Japan, and the company says the additional customer support will ensure that Blacktrace’s other brands, Dolomite Microfluidics and Syrris, will be well positioned to meet this demand. The new Japanese facility will also enable the company to host workshops and in-person meetings, solidifying relationships and providing stronger local support.

For further information about Blacktrace visit

Last modified onMonday, 03 December 2018 10:51

Related items

Latest from Tom Mulligan